共 2 条
- [1] Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer. Jacobs T W, Gown A M, Yaziji H, et al. Journal of Clinical Oncology . 1999
- [2] Neu/erbB-2 amplification idetifies a poor-prognosis group of women with node-negative breast cancer.Toronto Breast Cancer Study Group. Andrulis DC, Bull SB, Blackstein ME, et al. Journal of Clinical Oncology . 1998